Public Awareness of Cord Blood Opportunities Lagging
Recent studies indicate that a lack of public education about cord-blood-derived adult stem cells is hindering therapeutic progress.
August 30, 2009
Recent studies indicate that a lack of public education about cord-blood-derived adult stem cells is hindering therapeutic progress.
Vet-Stem, the highly successful U.S. veterinary adult stem cell company, now offers a service which allows for an "everlasting" supply of adult stem cells.
Scientists in Germany have simplified the iPS (induced pluripotent stem) cell reprogramming procedure from four genes to one gene, though the choice of cell type plays an important role.
At last, for the first time, Geron offers an explanation for the FDA-imposed hold on its highly publicized human embryonic stem cell clinical trial.
Doctors in Houston use autologous adult stem cell therapy to treat heart failure in an FDA-approved clinical trial.
Russia’s Human Stem Cell Institute has announced that it is seeking funding from investors in what promises to be Russia’s first initial public offering in over a year.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2025, Stem Cell Insitute Panama. All rights reserved.